Related Experiment Video
Updated: Jul 15, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Assessing activity of pediatric Crohn's disease: which index to use?
1Division of Gastroenterology/Clinical Nutrition, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Canada.
Insights
The Pediatric Crohn's Disease Activity Index (PCDAI) better distinguishes pediatric Crohn's disease activity levels than the adult Crohn's Disease Activity Index (CDAI). PCDAI shows stronger correlations with key inflammation markers.
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
- Clinical Assessment Tools
Background:
- The Pediatric Crohn's Disease Activity Index (PCDAI) was developed for pediatric patients, incorporating growth and laboratory markers.
- The adult Crohn's Disease Activity Index (CDAI) relies more on subjective symptoms.
Purpose of the Study:
- To compare the feasibility, validity, and responsiveness of PCDAI versus CDAI in pediatric Crohn's disease.
- To determine which index better assesses disease activity in children and adolescents.
Main Methods:
- Eighty-one pediatric patients with Crohn's disease were evaluated.
- Gastroenterologists provided global assessments of disease activity (quiescent to severe).
- CDAI and PCDAI scores were calculated independently.
Main Results:
- Both PCDAI and CDAI showed significant differences in scores across disease activity levels.
- PCDAI demonstrated less score overlap between strata compared to CDAI.
- PCDAI correlated better with serum orosomucoid and platelet count.
Conclusions:
- Both PCDAI and CDAI are effective in reflecting disease activity in pediatric Crohn's disease.
- PCDAI exhibits superior ability in discriminating between varying levels of disease activity in pediatric patients.
Background & Aims:
The Pediatric Crohn's Disease Activity Index (PCDAI) is a multi-item measure that, in contrast to the adult-derived CDAI, includes linear growth and places less emphasis on subjectively reported symptoms but more on laboratory parameters of intestinal inflammation. This study compared the feasibility, validity, and responsiveness of PCDAI vs. CDAI in the assessment of Crohn's disease activity among pediatric patients.
Methods:
Eighty-one children and adolescents with Crohn's disease were studied. A gastroenterologist provided a categorical global assessment of disease activity as quiescent, mild, moderate, or severe after interview and physical examination. CDAI and PCDAI scores were calculated by an independent appraiser.
Results:
Mean values within each category for CDAI and PCDAI differed significantly between strata. PCDAI values were quiescent, 6.8 +/- 6. 6; mild, 18.7 +/- 7.3; moderate, 38.5 +/- 12.9; and severe, 54.2 +/- 14.0. CDAI values were quiescent, 23.5 +/- 53.6; mild, 96.0 +/- 60. 7; moderate, 184.5 +/- 97.0; and severe, 284.4 +/- 85.8. Individual scores showed less overlap between strata for PCDAI than for CDAI. PCDAI showed better correlation with serum orosomucoid and platelet count, laboratory parameters of inflammation not included in either index.
Conclusions:
Both PCDAI and CDAI reflect disease activity in pediatric Crohn's disease. PCDAI is better at discriminating between levels of disease activity.
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems related to...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations

